FDA approves updated 2026-2027 COVID vaccines including Moderna's Spikevax and mNEXSPIKE
The FDA approved updated 2026-2027 COVID vaccines on Thursday, clearing the way for manufacturers to ship doses to pharmacies and doctors' offices. Moderna's updated Spikevax and mNEXSPIKE formulas were approved and are expected to become available in the coming days, though agency criteria and a legal dispute could complicate access for some people.
Detected & updated continuously · Source: Nebula
Story subjects
Sources
@nytimes
The FDA approved updated Covid vaccines on Thursday, clearing the way for manufacturers to ship doses to pharmacies and doctors’ offices. But criteria set by the agency and a legal dispute could complicate access for some people. https://t.co/lLJTo2NfN5
@PolymarketMoney
BREAKING: FDA has approved Moderna’s updated 2026–2027 COVID formulas with new Spikevax and mNEXSPIKE vaccines expected to become available in the coming days.